today EuroPerio Copenhagen June 15 & 16, 2022
EFP welcomes attendees to EuroPerio10 in Copenhagen
/ Interview: “I am looking forward to the best EuroPerio ever”
/ News
/ Interview: New study findings on Xeal and TiUltra surfaces with All-on-4 treatment concept
/ Industry
/ What’s on in Copenhagen, 15–18 June
Array
(
[post_data] => WP_Post Object
(
[ID] => 85126
[post_author] => 0
[post_date] => 2022-06-15 07:02:41
[post_date_gmt] => 2022-06-09 09:02:28
[post_content] =>
[post_title] => today EuroPerio Copenhagen June 15 & 16, 2022
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => today-copenhagen-june-15-16-2022
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:29
[post_modified_gmt] => 2024-10-24 07:19:29
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/epaper/today-copenhagen-june-15-16-2022/
[menu_order] => 0
[post_type] => epaper
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85126
[id_hash] => 4041a410a673d78a60d58c2441b92de7f95dc9bdbb3f737dd0d721abacc08cda
[post_type] => epaper
[post_date] => 2022-06-15 07:02:41
[fields] => Array
(
[pdf] => Array
(
[ID] => 85127
[id] => 85127
[title] => today Copenhagen June 15 &16, 2022.pdf
[filename] => today Copenhagen June 15 &16, 2022.pdf
[filesize] => 0
[url] => https://e.dental-tribune.com/wp-content/uploads/today Copenhagen June 15 &16, 2022.pdf
[link] => https://e.dental-tribune.com/epaper/today-copenhagen-june-15-16-2022/today-copenhagen-june-15-16-2022-pdf-2/
[alt] =>
[author] => 0
[description] =>
[caption] =>
[name] => today-copenhagen-june-15-16-2022-pdf-2
[status] => inherit
[uploaded_to] => 85126
[date] => 2024-10-24 07:19:23
[modified] => 2024-10-24 07:19:23
[menu_order] => 0
[mime_type] => application/pdf
[type] => application
[subtype] => pdf
[icon] => https://e.dental-tribune.com/wp-includes/images/media/document.png
)
[cf_issue_name] => today Copenhagen June 15 & 16, 2022
[cf_edition_number] => 15062022
[publish_date] => 2022-06-15 07:02:41
[contents] => Array
(
[0] => Array
(
[from] => 1
[to] => 2
[title] => EFP welcomes attendees to EuroPerio10 in Copenhagen
[description] => EFP welcomes attendees to EuroPerio10 in Copenhagen
)
[1] => Array
(
[from] => 4
[to] => 4
[title] => Interview: “I am looking forward to the best EuroPerio ever”
[description] => Interview: “I am looking forward to the best EuroPerio ever”
)
[2] => Array
(
[from] => 6
[to] => 16
[title] => News
[description] => News
)
[3] => Array
(
[from] => 17
[to] => 17
[title] => Interview: New study findings on Xeal and TiUltra surfaces with All-on-4 treatment concept
[description] => Interview: New study findings on Xeal and TiUltra surfaces with All-on-4 treatment concept
)
[4] => Array
(
[from] => 18
[to] => 20
[title] => Industry
[description] => Industry
)
[5] => Array
(
[from] => 22
[to] => 22
[title] => What’s on in Copenhagen, 15–18 June
[description] => What’s on in Copenhagen, 15–18 June
)
)
[seo_title] =>
[seo_description] =>
[seo_keywords] =>
[fb_title] =>
[fb_description] =>
)
[permalink] => https://e.dental-tribune.com/epaper/today-copenhagen-june-15-16-2022/
[post_title] => today EuroPerio Copenhagen June 15 & 16, 2022
[client] =>
[client_slug] =>
[pages_generated] =>
[pages] => Array
(
[1] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-0.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-0.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-0.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-0.jpg
[1000] => 85126-f3c954f0/1000/page-0.jpg
[200] => 85126-f3c954f0/200/page-0.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[2] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-1.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-1.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-1.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-1.jpg
[1000] => 85126-f3c954f0/1000/page-1.jpg
[200] => 85126-f3c954f0/200/page-1.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[3] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-2.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-2.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-2.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-2.jpg
[1000] => 85126-f3c954f0/1000/page-2.jpg
[200] => 85126-f3c954f0/200/page-2.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85128
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-3-ad-85128
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-3-ad-85128
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-3-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85128
[id_hash] => 1f1cb084efdd036fda90b43794661d19965b75dccae962df209516d791ffef94
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/3shape/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-3-ad-85128/
[post_title] => epaper-85126-page-3-ad-85128
[post_status] => publish
[position] => 0.625,0.21881838074398,98.75,99.124726477024
[belongs_to_epaper] => 85126
[page] => 3
[cached] => false
)
)
[html_content] =>
)
[4] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-3.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-3.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-3.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-3.jpg
[1000] => 85126-f3c954f0/1000/page-3.jpg
[200] => 85126-f3c954f0/200/page-3.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[5] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-4.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-4.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-4.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-4.jpg
[1000] => 85126-f3c954f0/1000/page-4.jpg
[200] => 85126-f3c954f0/200/page-4.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85129
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-5-ad-85129
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-5-ad-85129
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-5-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85129
[id_hash] => 3d2c44a294171a768d686a4051e5ae0b1d43028d83d5d99e97f411425c68afb6
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/straumann/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-5-ad-85129/
[post_title] => epaper-85126-page-5-ad-85129
[post_status] => publish
[position] => 0.3125,0.43763676148796,98.75,98.90590809628
[belongs_to_epaper] => 85126
[page] => 5
[cached] => false
)
)
[html_content] =>
)
[6] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-5.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-5.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-5.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-5.jpg
[1000] => 85126-f3c954f0/1000/page-5.jpg
[200] => 85126-f3c954f0/200/page-5.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[7] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-6.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-6.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-6.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-6.jpg
[1000] => 85126-f3c954f0/1000/page-6.jpg
[200] => 85126-f3c954f0/200/page-6.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85130
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-7-ad-85130
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-7-ad-85130
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-7-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85130
[id_hash] => 7a00f928a8e8b93f454a1454230549bfbb4d369b26b604ec731817c57c05fa0b
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/nobel-biocare-services-ag/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-7-ad-85130/
[post_title] => epaper-85126-page-7-ad-85130
[post_status] => publish
[position] => 0.3125,0.43763676148796,99.375,98.90590809628
[belongs_to_epaper] => 85126
[page] => 7
[cached] => false
)
)
[html_content] =>
)
[8] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-7.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-7.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-7.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-7.jpg
[1000] => 85126-f3c954f0/1000/page-7.jpg
[200] => 85126-f3c954f0/200/page-7.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85131
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-8-ad-85131
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-8-ad-85131
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-8-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85131
[id_hash] => 5844ebc4d7c31b9c318e541727411b126c9dcbb4523d408043d43732a7200af1
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/acteon-group/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-8-ad-85131/
[post_title] => epaper-85126-page-8-ad-85131
[post_status] => publish
[position] => 0.3125,24.288840262582,75.3125,75.492341356674
[belongs_to_epaper] => 85126
[page] => 8
[cached] => false
)
)
[html_content] =>
)
[9] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-8.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-8.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-8.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-8.jpg
[1000] => 85126-f3c954f0/1000/page-8.jpg
[200] => 85126-f3c954f0/200/page-8.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85132
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-9-ad-85132
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-9-ad-85132
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-9-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85132
[id_hash] => 7801bfd723952bb7f8c16ea6b2b78f05f6c515a8159f7e4aafee724716d1b8e1
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/straumann/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-9-ad-85132/
[post_title] => epaper-85126-page-9-ad-85132
[post_status] => publish
[position] => 0.3125,0.21881838074398,98.75,98.90590809628
[belongs_to_epaper] => 85126
[page] => 9
[cached] => false
)
)
[html_content] =>
)
[10] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-9.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-9.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-9.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-9.jpg
[1000] => 85126-f3c954f0/1000/page-9.jpg
[200] => 85126-f3c954f0/200/page-9.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85133
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-10-ad-85133
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-10-ad-85133
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-10-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85133
[id_hash] => d68d3a17ce1be02148607a9548d4bb127440aa715e1cbeb422aa88a036edbea3
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/osstem/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-10-ad-85133/
[post_title] => epaper-85126-page-10-ad-85133
[post_status] => publish
[position] => 0.625,49.671772428884,98.125,50.109409190372
[belongs_to_epaper] => 85126
[page] => 10
[cached] => false
)
)
[html_content] =>
)
[11] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-10.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-10.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-10.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-10.jpg
[1000] => 85126-f3c954f0/1000/page-10.jpg
[200] => 85126-f3c954f0/200/page-10.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[12] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-11.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-11.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-11.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-11.jpg
[1000] => 85126-f3c954f0/1000/page-11.jpg
[200] => 85126-f3c954f0/200/page-11.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85134
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-12-ad-85134
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-12-ad-85134
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-12-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85134
[id_hash] => d765144b2bf12672a2e68e6890d5b333ad89197e3fe969accadcad69397623fd
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dtstudyclub.com/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-12-ad-85134/
[post_title] => epaper-85126-page-12-ad-85134
[post_status] => publish
[position] => 5.625,50.109409190372,43.4375,42.888402625821
[belongs_to_epaper] => 85126
[page] => 12
[cached] => false
)
)
[html_content] =>
)
[13] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-12.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-12.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-12.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-12.jpg
[1000] => 85126-f3c954f0/1000/page-12.jpg
[200] => 85126-f3c954f0/200/page-12.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85135
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-13-ad-85135
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-13-ad-85135
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-13-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85135
[id_hash] => fa196ac9521d4722ccb42a6e6c83f5d69cbafbb538a017c0d055d71aa8bd3695
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/camlog/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-13-ad-85135/
[post_title] => epaper-85126-page-13-ad-85135
[post_status] => publish
[position] => 0.3125,0.21881838074398,98.75,99.343544857768
[belongs_to_epaper] => 85126
[page] => 13
[cached] => false
)
)
[html_content] =>
)
[14] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-13.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-13.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-13.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-13.jpg
[1000] => 85126-f3c954f0/1000/page-13.jpg
[200] => 85126-f3c954f0/200/page-13.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[15] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-14.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-14.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-14.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-14.jpg
[1000] => 85126-f3c954f0/1000/page-14.jpg
[200] => 85126-f3c954f0/200/page-14.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85136
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-15-ad-85136
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-15-ad-85136
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-15-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85136
[id_hash] => 7e6bb20282cb9efc32fba38deb6273321157800198188a7ae2cf94ac1f49a181
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/sprintray/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-15-ad-85136/
[post_title] => epaper-85126-page-15-ad-85136
[post_status] => publish
[position] => 0.625,0.21881838074398,99.0625,99.343544857768
[belongs_to_epaper] => 85126
[page] => 15
[cached] => false
)
)
[html_content] =>
)
[16] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-15.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-15.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-15.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-15.jpg
[1000] => 85126-f3c954f0/1000/page-15.jpg
[200] => 85126-f3c954f0/200/page-15.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[17] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-16.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-16.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-16.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-16.jpg
[1000] => 85126-f3c954f0/1000/page-16.jpg
[200] => 85126-f3c954f0/200/page-16.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[18] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-17.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-17.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-17.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-17.jpg
[1000] => 85126-f3c954f0/1000/page-17.jpg
[200] => 85126-f3c954f0/200/page-17.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[19] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-18.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-18.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-18.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-18.jpg
[1000] => 85126-f3c954f0/1000/page-18.jpg
[200] => 85126-f3c954f0/200/page-18.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85137
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-19-ad-85137
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-19-ad-85137
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-19-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85137
[id_hash] => 790f075d5e1c7876b9cf8f1065ca8098bdfdf0e3c83b6c2bbf67f204f63856bb
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/e-m-s-electro-medical-systems-s-a/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-19-ad-85137/
[post_title] => epaper-85126-page-19-ad-85137
[post_status] => publish
[position] => 0.3125,0.21881838074398,98.75,99.562363238512
[belongs_to_epaper] => 85126
[page] => 19
[cached] => false
)
)
[html_content] =>
)
[20] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-19.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-19.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-19.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-19.jpg
[1000] => 85126-f3c954f0/1000/page-19.jpg
[200] => 85126-f3c954f0/200/page-19.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[21] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-20.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-20.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-20.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-20.jpg
[1000] => 85126-f3c954f0/1000/page-20.jpg
[200] => 85126-f3c954f0/200/page-20.jpg
)
[ads] => Array
(
[0] => Array
(
[post_data] => WP_Post Object
(
[ID] => 85138
[post_author] => 0
[post_date] => 2024-10-24 07:19:23
[post_date_gmt] => 2024-10-24 07:19:23
[post_content] =>
[post_title] => epaper-85126-page-21-ad-85138
[post_excerpt] =>
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => epaper-85126-page-21-ad-85138
[to_ping] =>
[pinged] =>
[post_modified] => 2024-10-24 07:19:23
[post_modified_gmt] => 2024-10-24 07:19:23
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://e.dental-tribune.com/ad/epaper-85126-page-21-ad/
[menu_order] => 0
[post_type] => ad
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[id] => 85138
[id_hash] => 1b93299c97fa5cf0972d74da17dbaaef956683c3d9de16c49a212c97a0307732
[post_type] => ad
[post_date] => 2024-10-24 07:19:23
[fields] => Array
(
[url] => https://www.dental-tribune.com/c/curaden-ag/
[link] => URL
)
[permalink] => https://e.dental-tribune.com/ad/epaper-85126-page-21-ad-85138/
[post_title] => epaper-85126-page-21-ad-85138
[post_status] => publish
[position] => 0.3125,0.43763676148796,99.0625,99.124726477024
[belongs_to_epaper] => 85126
[page] => 21
[cached] => false
)
)
[html_content] =>
)
[22] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-21.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-21.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-21.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-21.jpg
[1000] => 85126-f3c954f0/1000/page-21.jpg
[200] => 85126-f3c954f0/200/page-21.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[23] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-22.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-22.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-22.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-22.jpg
[1000] => 85126-f3c954f0/1000/page-22.jpg
[200] => 85126-f3c954f0/200/page-22.jpg
)
[ads] => Array
(
)
[html_content] =>
)
[24] => Array
(
[image_url] => Array
(
[2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/2000/page-23.jpg
[1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/1000/page-23.jpg
[200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/200/page-23.jpg
)
[key] => Array
(
[2000] => 85126-f3c954f0/2000/page-23.jpg
[1000] => 85126-f3c954f0/1000/page-23.jpg
[200] => 85126-f3c954f0/200/page-23.jpg
)
[ads] => Array
(
)
[html_content] =>
)
)
[pdf_filetime] => 1729754363
[s3_key] => 85126-f3c954f0
[pdf] => today Copenhagen June 15 &16, 2022.pdf
[pdf_location_url] => https://e.dental-tribune.com/tmp/dental-tribune-com/85126/today Copenhagen June 15 &16, 2022.pdf
[pdf_location_local] => /var/www/vhosts/e.dental-tribune.com/httpdocs/tmp/dental-tribune-com/85126/today Copenhagen June 15 &16, 2022.pdf
[should_regen_pages] => 1
[pdf_url] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85126-f3c954f0/epaper.pdf
[pages_text] => Array
(
[1] =>
TDI0322_01-24.pdf
14
15
16
Copenhagen · 15 and 16 June 2022
Interview
News
Products
Prof. Phoebus Madianos discloses what attendees can look forward to at this year’s
EuroPerio.
The European Federation of Periodontology
has made sustainability a central focus of
EuroPerio10.
EuroPerio offers the opportunity to see and
try out the most current innovations in periodontics and implant dentistry.
» page 6
» pages 17–20
» page 4
© d.ee_angelo/Shutterstock.com
EFP welcomes attendees
to EuroPerio10 in Copenhagen
“We aim to inspire excellence
during this year’s EuroPerio”
More than 130 speakers from over 30 countries
to present on advances in periodontics and implant dentistry
An interview with Holger Essig, chief marketing officer of BioHorizons Camlog
© Marina Datsenko/Shutterstock.com
Organised by the European Federation of
Periodontology (EFP), EuroPerio10 is being
held from 15 to 18 June at Bella Center Copenhagen in Denmark. EuroPerio, the leading congress in periodontics and implant dentistry,
is usually held triennially, but had to be postponed last year because of the pandemic.
EuroPerio10 has an impressive speaker lineup of more than 130 experts from over 30 countries who will cover the latest trends in perio-
dontics and implant dentistry and their connection with other dental and medical disciplines.
With its wide range of scientific formats,
EuroPerio10 has educational opportunities for
general dentists, periodontists, oral surgeons,
orthodontists, prosthodontists, dental hygienists, dental nurses, other dental and medical
` page 2
As dental professionals around the world gear
up for EuroPerio10, Dental Tribune International
reached out to Holger Essig, chief marketing officer of BioHorizons Camlog and a member of
Henry Schein’s Global Oral Reconstruction Group,
to discuss the company’s participation at the
event and its latest initiatives.
Mr Essig, in 2018, CAMLOG’s theme for EuroPerio
was “Perio-friendly and efficient restorations
with CAMLOG”. Does BioHorizons Camlog have a
congress theme for this year’s show? Which are
the main topics that your company is covering
during the event?
It was after EuroPerio9, while attending the
2019 International Dental Show, that we formed
BioHorizons Camlog as a combined brand, “inspiring excellence in oral reconstruction”. We
continue to aim to inspire excellence also during this year’s EuroPerio.
Long-lasting and highly aesthetic results in
implant dentistry depend on many factors: quality in execution and product, ease of use of the
products and workflows, including the digital
workflow in implantology. Additionally, scientific evidence for the implant solution and biologics chosen is of great importance. However,
as surgical techniques and possibilities progress, disseminating knowledge and facilitating
surgical skills in applying our innovative portfolio of biologics are the centre of our participation in EuroPerio10.
What sorts of products and activities can attendees of EuroPerio10 look forward to at the
BioHorizons Camlog booth?
We are offering an Expert Lounge programme, and throughout Thursday and Friday,
renowned experts are holding live presenta` page 2
AD
h
With patented triple formula of
olive oil, castor oil and triple
oxygen (ozone).
io n
ess al
Dental materials
inspired by nature
u se
PeriO3 Oil
pro
f
Whether chronic or acute gingivitis, stomatitis or cheilitis, prophylaxis or
periimplantitis. Whether for home use or dental studios or clinics.
e
om use
A cooling gel to be applied in
the pockets and after deep
cleaning to promote healing.
Pure natural product.
TASTER 1 x PeriO3 Oil for professional users in studios and clinics
OFFER 1 x Gingiva Fit for patients to use at home
30 €
Neither discoloration nor tongue numbness, neither skin irritation nor taste distortion,
neither antibiotics nor cortisone additives: PeriO3 Oil – the gentle alternative to chlorhexidine.
Recommended by leading periodontists. Approved for all patient groups including small children, pregnant women and nursing mothers.
incl.
VAT
Hoffmann Dental Manufaktur GmbH
T +49 30 820 09 90
www.hoffmann-dental.com
Find us at Booth
C3.08
[2] =>
TDI0322_01-24.pdf
news
_ page 1 “EFP welcomes…”
professionals, and dental students. The formats include live mucogingival and bone regeneration surgeries, interactive sessions,
nightmare sessions illustrating worst-case
treatment scenarios, video sessions, debates,
interviews and symposia. Particular attention
will be devoted to the EFP clinical guidelines
on the treatment of periodontitis. Additionally,
the latest guideline on the treatment of Stage IV
periodontitis will be presented at the congress.
“The scientific programme addresses the
interests of every member of the dental community and provides them with an updated
snapshot of what perio is today,” explained
Prof. David Herrera, scientific chair of EuroPerio10, in a press release. “We have a great
faculty, complete and diverse, addressing the
main challenges of our profession with the
most engaging session formats.”
In addition to the regular programme,
EuroPerio10 offers participants the opportunity
to attend sponsored workshops and networking
events, such as the welcome reception on
Wednesday evening. Other highlights of the
congress include abstract presentations, contests, award ceremonies, a major industry exhibition and the EFP Village as the meeting point
for the dozens of national societies that constitute the EFP.
“EuroPerio is the main event organised by
the EFP and appeals to a large, global audience,” said Prof. Lior Shapira, past president
of the EFP. The latest editions—EuroPerio8 in
London in the UK in 2015 and EuroPerio9 in
Amsterdam in the Netherlands in 2028—each
© Oliver Foerstner/Shutterstock.com
The Bella Center Copenhagen is Scandinavia’s largest multifunctional event venue.
attracted around 10,000 attendees from more
than 100 countries.
© EFP
© EFP
Prof. David Herrera, scientific chair of EuroPerio10.
_ page 1 “We aim to inspire …”
tions, discussions and hands-on workshops at
our booth, E20.
For the hands-on workshops, we have created
an environment of close interaction and exchange
by keeping the number of participants small, only
allowing up to six clinicians at a time. Dr Gerhard
Iglhaut (Germany), Prof. Anton Sculean (Switzerland), Dr Andres Pascual (Spain) and Dr Maria
Geisinger (US) are leading the programme. Key topics include soft-tissue management in guided bone
regeneration, around implants and in root coverage
applying NovoMatrix, a novel acellular dermal matrix, as well as BioHorizons Camlog’s comprehensive portfolio of dental implants and biologics.
We are also offering the Expert Challenge
with a hands-on competition and live knowledge
quiz that will provide a wonderful opportunity
for participation, exchange, networking and fun.
2
15 and 16 June 2022
Commenting on the growing participant
numbers, Prof. Phoebus Madianos, chair of
Prof. Lior Shapira, past president of the European Federation of Periodontology.
EuroPerio10 is one of the first larger international shows to take place since the COVID-19
pandemic began. What’s the significance of
EuroPerio for your company, and what are you
personally looking forward to?
The EuroPerio meetings have always been
very important for sharing the latest scientific
results, offering education and receiving feedback from the dental community on our product
portfolio and innovations. We look forward to a
vibrant and lively meeting and exchange with
dental professionals. Personally, I am excited to
meet with many friends from the industry and
teammates from our global team whom I have
not seen in person for quite a while.
This year, BioHorizons Camlog is presenting
the Global Education Tour. Three events already
took place in Egypt, Ecuador and Hungary in
March and April. How were these events re-
ceived by participants, and what are some of
the other highlights that dental professionals
can look forward to this year?
So far, the feedback from the participants was excellent. The motto of the 2022
BioHorizons Camlog Global Education Tour is
“a passport to successful outcomes through advanced implant therapy”. Together with our distribution partners, we are proud to host these
events to provide top education locally. Events in
Athens, Bogota and Mexico City will follow
throughout the year.
In addition, we are very proud to be the
founding sponsor of the Oral Reconstruction
Foundation. We just held an international
symposium in Orlando in Florida in the US,
and the foundation will be hosting a three-day
international symposium, including a dental
technicians’ day, in Munich in Germany this
October.
EuroPerio10, said in an interview: “The reason
why participant numbers have increased over
the years is simply because it is the world’s leading congress in periodontics and implant dentistry and has the best speakers, the latest topics and many opportunities to network with colleagues from all over the world.”
In response to being asked what dental professionals can look forward to at the congress,
he replied: “They will be able to learn from the
best experts in the world, since there is a faculty
of more than 120 top international speakers.
They can update and expand their skills and
their knowledge with authoritative, state-of-theart presentations on all hot periodontics topics.”
He continued: “They can choose from a
huge variety of topics and approaches and enjoy the certainty that, at any given moment,
there will be a session that is just perfect for
them. They can network, build relationships
with colleagues, discuss ideas, draw up projects
and find the latest proposals from the dental industry. They can enjoy a lively congress in a
lovely city. All in all, for four days, they can see
what periodontics and implant dentistry will
look like in the coming years.”
The EFP was founded in 1991 and is an umbrella organisation of 30 national scientific societies devoted to promoting research, education
and awareness of periodontal science and practice.
What are some of BioHorizons Camlog’s future
aspirations? What will your company be focusing on in the near future?
We will continue to concentrate on excellence in oral reconstruction through our focus
on quality, satisfaction and support and by creating added value and innovations for our customers around the world. Our team plays a central role in achieving this. We are proud and
thankful to have such excellent and loyal team
members and partners in many parts of the
world. That is why investing in our team and
continuing to build strong relationships—with
industry partners and customers—will remain a
strong part of our focus.
Editorial note: BioHorizons Camlog is a gold sponsor of
EuroPerio10 and is present at the congress with its Expert
Lounge at Booth E20.
[3] =>
TDI0322_01-24.pdf
3Shape TRIOS
Better for them.
Better for you.
Better patient care today and tomorrow.
There’s really no better way to counsel patients than by
showing them their unique dentition. 3Shape TRIOS®
helps add weight to your recommendations. Which,
in turn, improves case acceptance. We think
you’ll find your patients are happier, too.1
And your practice more successful.
What could be better than that?
Explore more at 3Shape.com
1. 80% of studies (4 of 5) show patients choose digital impressions over conventional. 88% of studies (7 of 8)
show clinicians choose digital impressions over conventional (Chandran et al. 2019).
[4] =>
TDI0322_01-24.pdf
interview
“I am looking forward to the best EuroPerio ever”
An interview with Prof. Phoebus Madianos, chair of EuroPerio10
Ahead of this year’s EuroPerio congress in Copenhagen, Dental
Tribune International spoke with Prof. Phoebus Madianos, professor
in the Department of Periodontics at the National and Kapodistrian
University of Athens in Greece and chair of EuroPerio10, about the
return of the record-breaking event and what attendees can expect.
Prof. Madianos, last year, the European Federation of Periodontology
(EFP) celebrated the 30th anniversary of its foundation. In your
opinion, what have been the greatest achievements and milestones of the society?
The EFP’s greatest achievement has been becoming the global
benchmark community in periodontics and implant dentistry from
a scientific point of view. It is the world’s leading platform for key
stakeholders, not only periodontal scientists and clinicians but also
dentists, researchers, policymakers, practices, companies, and other
dental and health professionals.
Primarily, we achieved this not only through our continuous
leadership and the prestige of our meetings—the EuroPerio congresses, in particular—but also through our publications, campaigns
and outreach activities. Today, opinion leaders in the field of periodontal health and disease from around the globe draw on the EFP’s
expertise.
Aside from EuroPerio, over the last 30 years the EFP has had
several other major milestones. These were the success of its Perio
Workshops (organised since 1993) and accredited postgraduate programmes in periodontics (initiated in 1998), the creation of our website and the founding in 2014 of the Perio Master Clinic triennial
conference for clinicians. In addition, the EFP’s annual awareness
event, Gum Health Day, was started in 2014, and we launched outreach campaigns in 2017, the first of which being the Oral Health
and Pregnancy campaign.
Regarding EuroPerio, one of the landmark events was EuroPerio1
in Paris in 1994, when 1,200 attendees made the congress a remarkable success and paved the way for future editions. EuroPerio7 was
held in Vienna in 2012, and it set new standards in terms of format,
professionalism and quality. EuroPerio9 was held in Amsterdam in
2018, and the threshold of 10,000 participants was passed for the first
time.
Owing to the SARS-CoV-2 pandemic, the EFP decided in 2020 to
postpone EuroPerio10 by one year and, consequently, the periodontics community has had to wait four years instead of three to
come together. In retrospect, was this the right decision?
When the pandemic hit Europe in March 2020, we were glad
that we had another year until the next instalment of EuroPerio.
As the pandemic progressed, it became clear that it would have
a much greater impact than originally expected. Therefore, the
EuroPerio10 organising committee, together with the EFP, took the
decision to postpone the congress by one year. As a result, future
EuroPerio congresses will also be held a year later than originally
planned. We are convinced that this was the right decision, and we
are confident that we will be able to hold the meeting that we all
hope for in June 2022. Hence, EuroPerio, the “Olympic games” of
dental congresses, will take place four years after the last one, just
like the Olympics!
© Image: EFP
Prof. Phoebus Madianos.
was excited about educational content. At the same time, periodontics professionals all over the world faced a lack of in-person educational opportunities. We wanted to continue promoting the June
2022 event by looking back at previous editions of the congress
as well as highlighting various topics on the already published
EuroPerio10 scientific programme; in other words, we helped to promote the event by sharing scientific education. A second aim of the
virtual EuroPerio Series was to extend the reach of EFP education
to an audience who had not previously attended EFP meetings.
We started with a free kick-off event in June 2021, and this
was hosted at the Bella Center, the venue in Copenhagen where
EuroPerio10 had been due to take place. This event, titled “Mucogingival surgery—from Amsterdam to Copenhagen”, used the legendary live surgery from EuroPerio9 in Amsterdam as a springboard to
review and discuss a series of clinical problems with a renowned
panel of experts in mucogingival surgery. This online event was attended by more than 2,000 participants from all over the world, and
we continued with monthly sessions that were accessible free of
charge to everyone who had already registered for EuroPerio10.
Feedback on these sessions has been positive, but we know
that, whereas virtual education is a suitable substitute, it will never
replace in-person get-togethers.
The past two years must have been a challenge for scientific communities like the EFP. How did collaboration change as the
COVID-19 crisis raged on?
The pandemic drastically reduced the number and frequency
of patient visits to dental clinics. Fear of infection and often
misinformation prevented many people from keeping up with treatments. The EFP felt that it was appropriate to provide its affiliated
societies and the 16,000 oral healthcare professionals it represents
with a COVID-19 safety protocol in order to help them operate safely.
In addition, we launched a campaign to encourage people to visit
their dentist and to continue to take care of their oral health.
Personal interaction and networking are very much relied upon
within the scientific community and in the area of education. These
have only been possible throughout the past two years by changing
our concepts of interaction and moving towards virtual communication and education rather than the in-person exchange of knowledge.
EuroPerio9 attracted a record-breaking 10,232 periodontists, dentists, dental students, and dental hygienists, as well as other dental
professionals, making it the largest event so far. Do you expect a
similar number of participants this year?
EuroPerio is all about quality not quantity. The reason why participant numbers have increased over the years is simply because
it is the world’s leading congress in periodontics and implant dentistry and has the best speakers, the latest topics and many opportunities to network with colleagues from all over the world.
As already mentioned, our greatest aim is to make the congress
as accessible as possible to anyone in the periodontics world. To
what extent interested participants will still face travel restrictions
or similar challenges in June is something that we cannot foresee.
We have never faced a situation like this pandemic, and therefore,
it is also difficult to project what would be a realistic attendance for
this year’s edition.
Nonetheless, we are aiming for the best EuroPerio ever and, if
we get close to the record attendance that we had in Amsterdam in
2018, we will be extremely happy.
In June 2021, the EFP launched a series of online scientific sessions that aimed to bridge the gap until the next in-person event in
2022. How has the EuroPerio Series been received and have these
online sessions proved to be a viable alternative to in-person
events?
Rather than putting everything on hold and continuing with it
all a year later, immediately after the postponement we discussed
ways in which we could maintain excitement and continue to promote our activities. We knew the global periodontics community
How can dental professionals benefit from attending EuroPerio10?
They will be able to learn from the best experts in the world
since there is a faculty of more than 120 top international speakers.
They can update and expand their skills and their knowledge with
authoritative, state-of-the-art presentations on all hot periodontics
topics. They can choose from a huge variety of topics and approaches and enjoy the certainty that, at any given moment, there
will be a session that is just perfect for them. They can network,
build relationships with colleagues, discuss ideas, draw up projects
4
15 and 16 June 2022
“EuroPerio, the ‘Olympic games’ of
dental congresses, will take place
four years after the last one, just like
the Olympics!”
and find the latest proposals from the dental industry. They can enjoy a lively congress in a lovely city. All in all, for four days, they can
see what periodontics and implant dentistry will look like in the
coming years.
As social distancing rules are still in place, what will networking
opportunities look like?
We will—for all aspects of the event—apply all hygiene and
safety measures that are reasonable and responsible at the time of
the meeting. We are planning networking opportunities, such as a
welcome reception and speakers’ dinner for the Wednesday and the
official congress evening event for the Saturday. However, we have
not yet planned a congress party for the Thursday. This casual afterwork party event was introduced at EuroPerio8 in London in 2015,
and at the Amsterdam event in 2018, it attracted 2,500 participants.
Currently, we do not feel that events like that should take place, but
we will make sure that our participants have ample networking opportunities.
In line with the EFP Sustainability Manifesto, the EFP has announced that this year’s EuroPerio will be more sustainable. Could
you please explain what that means?
At the EFP, we understand sustainability not only as an environmental issue but also as a broader challenge to the ways
in which we operate and think. It is one of our priorities. Often, modest changes have a big positive impact and help make a difference.
For EuroPerio10, we aim to reduce printed congress materials
by 50 %. When they are indispensable, printed materials will be
made from recycled paper. The lanyards that we will use will
be made only from recycled polyethylene terephthalate. Moreover,
EuroPerio10 attendees will receive public transportation tickets as
part of their registration package and all speakers who must reach
Copenhagen by plane will carbon compensate their flights.
What are you are personally most looking forward to?
Personally, I am looking forward to the best EuroPerio ever,
which will have the best in science, clinical practice and innovation.
Also, coming together with colleagues and friends after such a long
while is something that will be a highlight for me, as will be enjoying the atmosphere and having fun in and around the Bella Center
in Copenhagen!
[5] =>
TDI0322_01-24.pdf
V I SIT US A
BOOTH E0 T
5
Straumann Corporate Forum
Thursday, 16 June | 12.30 – 14.00 | Auditorium
Prof. Frank Schwarz will chair this session with two
world-renowned experts, Prof. Ronald Jung and Prof.
Helena Francisco, who will discuss the advantages
of immediate treatment protocols in various clinical
indications, with a special emphasis on effective soft
tissue management.
Prof. Frank
SCHWARZ
Prof. Helena
FRANCISCO
Prof. Ronald
JUNG
Chair
Straumann® TLX Implant System
Iconic Tissue Level meets
Immediacy.
DESIGNED FOR
IMMEDIATE PROTOCOLS
PERI-IMPLANT HEALTH
PRESERVATION
SIMPLICITY
AND EFFICIENCY
Fully tapered implant design for
optimized primary stability.
Reduced risk of nesting bacteria and
optimized cleansability.
One-stage process with restoration
at soft-tissue level allows to use chair
time more efficiently.
The design of the Straumann® TLX Implant takes into account key biological principles of hard and soft tissue healing.
It is designed to significantly reduce the risk of inflammation and bone resorption as the implant-abutment interface is
moved away from the bone. Contact your local Straumann representative now or visit www.straumann.com/tlx
References on www.straumann.com/tlx
[6] =>
TDI0322_01-24.pdf
news
Clinicians discuss their nightmare cases at EuroPerio10
Sessions highlight situations where everything went wrong
Typically, dental congresses provide an ideal
platform for speakers to present and discuss
some of their most notable achievements in clinical practice. Though these cases will be abundant at EuroPerio10, one of the most intriguing
elements of the event’s scientific programme
will be the two “nightmare sessions”, in which
experienced practitioners will detail treatments
that failed to go according to plan—and how
they reacted to these situations.
On Thursday, 16 June, from 2:30 p.m. to
4:00 p.m., Dr Adriàn Guerrero will chair a discussion titled “Nightmare session—dental implants”. Prof. Øystein Fardal, Dr Tiernan O’Brien
and Dr Luca Landi will reveal some of the cases
that, for one reason or another, had an outcome
vastly different from what was expected.
Dr O’Brien, for example, will focus on two specific cases that, in his words, “turned into nightmares for me and my patient”. In the first case,
a mistake at the beginning of treatment created
a problem that continues to persist for the patient 17 years later. In the second case, evidence-based treatment was provided in the correct way but, nonetheless, did not work and
ended up giving the patient a compromised final result.
“The nightmare session is really there to act
as a counterbalance to all the other talks that
will focus on the very positive results that can
be achieved in contemporary periodontal practice,” said Dr O’Brien.
“Our session is to remind people that not
everything works out as planned in every case.
In fact, we have been asked not just to present
cases that have not been successful, but cases
© Matej Kastelic/Shutterstock.com
that went very wrong and turned into a nightmare in one way or another,” he added.
The perils of periodontology
On Friday, 17 June, from 2:30 p.m. to
4:00 p.m., EFP past president Prof. Lior Shapira
will chair the event “Nightmare session—periodontal therapy”, and Prof. Moshe Goldstein,
Dr Pierpaolo Cortellini and Dr Giulio Rasperini
have all gamely opted to participate and share
some of the mistakes they have witnessed in
the course of their careers.
In the session, Dr Cortellini will discuss
managing complications in regenerative therapy and how certain treatment strategies and
techniques have been modified to achieve more
predictable results. He will analyse surgeries
that were not conducted correctly, the compromised outcomes that resulted and the possible
solutions for these cases. These will be compared with cases in which regenerative therapy
was performed without error.
Prof. Goldstein will elaborate on the potential complications and technique-sensitive nature of mucogingival surgery while providing
several case studies to illustrate what exactly
can go wrong when conducting this kind of
treatment. Dr Rasperini, meanwhile, will clarify
what, exactly, papilla reconstruction entails. As
one of the inventors of this treatment modality,
he is ideally positioned to explain the reasons
behind papilla loss and explore the mistakes
made in certain cases where this occurred.
According to Prof. Shapira, this second session “aims to show that expert periodontists
and key opinion leaders may have problems
during the healing following periodontal surgery”.
He added: “The biological and technical reasons for the failure need to be analysed, understood, and lead to modifications in the techniques. We can all benefit from the learning
process and need to follow the words of Albert
Einstein: ‘The only sure way to avoid making
mistakes is to have no new ideas.’”
© d.ee_angelo/Shutterstock.com
Sustainability: A central focus of EuroPerio10
EFP looks to make event more ecologically friendly
Though it has often been framed as just a
trend or an environmental issue, sustainability
is undeniably much more than that. It requires
businesses and industries across the world to
adapt their practices so that we can ensure that
a liveable planet will be maintained for future
generations. In recognition of this challenge, the
European Federation of Periodontology (EFP)
has made sustainability a key part of its mission
and even developed a sustainability manifesto
in 2021. Here are some of the ways in which sustainability will underpin the EuroPerio10 congress.
“At the EFP, we understand sustainability
not only as an environmental issue but also as
a broader challenge to the ways in which we operate and think,” Prof. Phoebus Madianos, chair
of EuroPerio10, told Dental Tribune International
in April. He noted that the event organisers
were aiming to half the total amount of printed
materials, would be using recycled paper for all
printouts and were encouraging digital alternatives.
Implementing sustainable
and ecological measures
The sustainability goals of EuroPerio10
broadly include reducing printed materials, decreasing the carbon footprint of event participants and encouraging all involved to reduce
waste and recycle when possible. The lanyards
being used are made entirely from recycled PET,
and many congress signs will be made from easily recycled cardboard. All EuroPerio10 attendees will receive public transportation tickets as
6
15 and 16 June 2022
part of their registration package, and all speakers who need to take a plane to reach Copenhagen will have the carbon emissions of their
flights offset.
In addition, the food options on offer at
EuroPerio10 are being sourced as locally as possible. One of the most sustainable cities in the world,
Copenhagen has set the goal of becoming carbonneutral by 2025 and has plenty of world-class restaurants that practise a sustainable and organic
approach to food sourcing and production.
The need for sustainability
The current lifestyle and resource consumption practices of humankind are unsustainable
in the long term, and professional congresses
tend to be particularly wasteful. According to
the EFP, an average conference attendee produces more than 2 kg of waste per day, and the
typical event wastes 15 %–20 % of the total food
it produces. Many disposable elements—water
bottles, brochures, lanyards and the like—are often made from plastic or paper and might not be
recycled properly even if that is a possibility.
To make EuroPerio10 as sustainable as it
can be, the EFP has asked that attendees make
certain small changes—together, these can have
a large impact. Instead of printing tickets, attendees will use the ticket confirmation barcode
emailed to them to print out a name badge upon
arrival. Congress participants are being encouraged to stay in an eco-friendly hotel in Copenha-
gen and to travel via public transport, bicycle or
electric taxi.
For those who need something in which to
stash their congress materials and goodies, the
EFP has launched a line of sustainable EuroPerio10
backpacks made out of recycled fibres. These stylish bags can be purchased at the event.
Overall, the success of these initiatives at
EuroPerio10 will rest largely on buy-in and support from attendees. For this reason, the EFP has
asked for the hashtag #EFPlanet to be used on
social media so that this message of sustainability can be communicated far and wide.
More information can be found at https://
www.efp.org/about-europerio/sustainability-ateuroperio10/.
[7] =>
TDI0322_01-24.pdf
Surface chemistry cells can’t resist.
Introducing Xeal and TiUltra – two new breakthrough surfaces derived from our decades
of applied anodization expertise. From abutment to implant apex, we have reimagined
surface chemistry and topography to optimize tissue integration at every level.
We’ve now entered the Mucointegration™ era.
The new Xeal surface is now
available for the On1™ Base
and the Multi-unit Abutment.
TiUltra is available on our best
selling NobelActive® and
NobelParallel™ CC implants.
[8] =>
TDI0322_01-24.pdf
news
New president inaugurated at EFP’s annual general assembly
European Federation of Periodontology affirms its commitment to support Ukraine
On 26 March, the European Federation of Periodontology (EFP) was
able to hold an in-person meeting for
the first time since 2019. The EFP’s
annual general assembly took place
in the Austrian capital of Vienna,
where a new president, Prof. Andreas
Stavropoulos, was welcomed and a
campaign launched to provide financial aid for Ukraine.
The “Help Ukraine” campaign is
planning to assist the Ukrainian people and refugees who have fled the
country by calling on the EFP’s 37 affiliated national societies of periodontics to raise at least € 30,000 in dona-
tions. The campaign was organised in
collaboration with the World Health
Organization-affiliated WHO Foundation, which works to deliver urgent
healthcare to the most vulnerable
groups.
“For the EFP, a European academic organisation within health and
medicine, it was a reasonable reaction to support fellow Europeans in
need,” stated Prof. Stavropoulos. “Our
donation campaign is a humanitarian
action,” he added.
Prof. Stavropoulos, a professor
of periodontics at Sweden’s Malmö
University, took over as president of
AD
Booth E13
the EFP from Prof. Lior Shapira. In
his first message since assuming the
role, Prof. Stavropoulos called for the
society’s members to work together
despite any differences, writing, “What
we have in common is much greater
than what separates us.”
“We should not let minor differences and special interests divide us
— we should stay united and continue
jointly working for the pan-European
recognition of periodontology as a
dental speciality, for the benefit of patients,” he continued.
Prof. Stavropoulos also made
special note of the upcoming
EuroPerio10, labelling it “the global
congress of periodontology par excellence”. The triennial congress will be
held at the Bella Center in Copenhagen in Denmark, the president’s
home country. First held in Paris in
1994, EuroPerio is one of the most
© EFP
7KHFOLQLFDOZRUNÀRZ
VROXWLRQIRU
,PSODQWRORJ\
E\$&7(21®
Prof. Andreas Stavropoulos.
Continuous
LPSODQWRORJ\
ZRUNVKRS
2Q$&7(21® booth E13
Expertise
& innovation
$FRPSUHKHQVLYHRႇHUFRYHULQJDOOWKH
VWHSVRIWKHLPSODQWRORJ\ZRUNÀRZ
Combining an expertise in imaging and
XOWUDVRXQG$FWHRQLVRႇHULQJLQQRYDWLYH
products, which help the implantologists
GHOLYHULQJ VDIH DQG FRPIRUWDEOH
SURFHGXUHVIURPGLDJQRVLVWRWUHDWPHQW
DQGIROORZXS
',$*1267,&
PLANNING
TREATMENT
)2//2:83
0HGLFDOGHYLFHVIRUPRUHLQIRUPDWLRQUHDGWKHLQVWUXFWLRQIRUXVHRUWKHODEHOOLQJGHGLFDWHGWRHDFKSURGXFW
SATELEC® A Company of ACTEON® Group
DYHQXH*XVWDYH(LႇHO ZI du Phare 33700 MERIGNAC FRANCE
ZZZDFWHRQJURXSFRP
important and largest educational
events for dental professionals specialising in periodontics and implant
dentistry. The previous iteration, held
in Amsterdam in the Netherlands, attracted a record-breaking 10,232 attendees from 111 countries in total.
According to the EFP, more than
6,000 people have already registered
for EuroPerio10.
The general consensus among attendees of the EFP’s general assembly was that an in-person meeting
was much needed after the predominantly online nature of meetings over
the past two years.
“I am so pleased that this year we
returned to a face-to-face GA [general
assembly] meeting and could greet
everyone in person,” said EFP Secretary General Prof. Nicola West.
She continued: “While online
meetings have their place in our sustainability strategy, face-to-face meetings are essential for our business to
operate, creating energy, warmth and
friendship, which cannot be underestimated.”
“When I became EFP president,
my wish was that my year would be
a ‘return to normal’ and, despite the
difficulties, I insisted on having an
in-person general assembly, which
was more than successful!” added
Prof. Shapira.
[9] =>
TDI0322_01-24.pdf
Zirconia
Implant System
Your partner in ortho
T
A
S
U
T
I
S
I
V
5
0
E
H
T
O
BO
Prosthetics perfected –
implants engineered.
axiomX3
®
B E Y O N D
F R O N T I E R S
[10] =>
TDI0322_01-24.pdf
news
Vaping’s unique connection to periodontal disease
Data suggests e-cigarette use promotes unique periodontal microbiome
Smoking tobacco has long been known to be
detrimental to oral health, but the risks of
newer simulations of smoking such as vaping
are less well-known though they are often believed to be healthier alternatives. Now, researchers from the New York University (NYU)
College of Dentistry have completed the first
study on the oral health of users of e-cigarettes.
They found that vaping created a unique periodontal microbiome, compared with that of
non-smokers and conventional cigarette smokers, and that participants who vaped experienced a worsened state of periodontal disease
at the end of the study.
The study compared the bacterial composition and cytokine concentrations of the subgingival plaque in conventional cigarette smokers,
e-cigarette users and non-smokers over the
course of six months. The participants in all
groups exhibited some evidence of periodontal
disease at baseline.
In the e-cigarette users, the detected cytokine levels indicated inflammation, but some
cytokines were at lower levels than expected.
The researchers believe this was possibly due to
the strains of bacteria present in those who
vaped but not present in those who smoked or
who had never smoked. The researchers hypothesised that it was possible that these bacteria were actively supressing the immune reactions that would normally have been expected.
Co-author of the study Fangxi Xu, a junior
research scientist at NYU, said in a press release:
“Vaping appears to be driving unique patterns
in bacteria and influencing the growth of some
AD
© Rommel Canlas/Shutterstock.com
The first longitudinal study on vaping has shown that e-cigarettes have deleterious effects on periodontal health.
bacteria in a manner akin to cigarette smoking,
but with its own profile and risks to oral health.”
Even worse was the finding that clinical attachment loss after six months was significantly
worse in the e-cigarette smokers. This was measured in the same groups of participants but in a
separate, earlier study, titled “Comparative effects of e-cigarette aerosol on periodontium of
periodontitis patients”, which was published online in September 2021 in Frontiers of Oral
Health.
Lead author of the most recent study
Dr Scott Thomas, an assistant research scientist
at NYU, said of the findings: “E-cigarette use is a
relatively new human habit. Unlike smoking,
which has been studied extensively for decades,
we know little about the health consequences
of e-cigarette use and are just starting to understand how the unique microbiome promoted by
vaping impacts oral health and disease.”
More long-term research is needed for dentists to feel comfortable offering counsel to their
patients regarding e-cigarette use. E-cigarettes
and alternative tobacco products fall under the
umbrella of what some call tobacco harm reduction.
Dental Tribune International reported that
a survey of German dentists by the German subsidiary of Philip Morris International (PMG), a
cigarette company moving towards smoke-free
products, found that 58% of the respondents did
not feel informed on the subject of tobacco
harm reduction and that 69% were not aware of
the concept.
Dr Charilaos Avrabos, then PMG’s manager
of scientific and medical affairs, claimed in a
2018 press briefing regarding the survey that “it
is clear that e-cigarettes are not risk-free products; neither are tobacco heating devices. For
non-smokers, these are not products that offer
any benefits. For smokers, who use the most
damaging form of nicotine delivery continually
over a period of years, switching to these products can make a huge difference by reducing
the amount of harmful substance.”
However, PMG’s claims seem to be contradicted by the findings of the NYU research and
the results of a 2020 study on vaping’s effect
on periodontal health. Senior author of that
study Dr Purnima Kumar, professor of periodontics at Ohio State University, said: “If you
stop smoking and start vaping instead, you
don’t move back toward a healthy bacterial profile but shift up to the vaping profile. Knowing
the vaping profile is pathogen-rich, you’re not
doing yourself any favours by using vaping to
quit smoking.”
The recent study, titled “Electronic cigarette
use promotes a unique periodontal microbiome”, was published in the February 2022 issue
of mBio.
[11] =>
TDI0322_01-24.pdf
NEW PERSPECTIVE ON
MANAGEMENT OF DENTAL BIOFILM
JOIN THE LUNCH SEMINAR:
June 16, 12.30-13.30pm
Seminar Room/Break Out 2, C1-M1
and request a sample on Stand C2.12.
Johnson & Johnson underlines its industry-leading
oral care expertise with a not-to-be-missed
EuroPerio10 seminar:
Research scientists Dr J Milleman and K Milleman
to announce revealing results from two clinical
studies reviewing the effects of essential oil mouth
rinse in oral hygiene regimes. Comparative efficacy
of mouth rinse and hygienist performed flossing
established for inhibiting the development of the
dental biofilm.
Professor Nicole Arweiler discusses the
Contemporary Management of the Oral
Microbiome and Dental Biofilm.
[12] =>
TDI0322_01-24.pdf
news
A modern, unmatched and compelling clinical protocol for prophylaxis
Dr Neha Dixit discusses Guided Biofilm Therapy
Petersilka et al. said: “If a new form of therapy is to be considered worth integrating into
standard periodontal therapy, it either has to be
superior in therapy outcome or has to show
other relevant advantageous aspects such as patient preference or operator convenience or
economy of time or other resources.”1
Focusing on oral hygiene, which forms the
gateway to maintaining good oral and systemic
health, is the need of the moment. The Guided
Biofilm Therapy (GBT) protocol represents and
follows the recommendations of the European
Federation of Periodontology, stating that to
have a successful treatment outcome, professional prophylaxis must be complemented by
equally good oral hygiene at home.
GBT is part of a comprehensive preventive
concept that aims not only to preserve patients’
oral health but also to improve patient compliance and subsequent recall attendance. It is a
modular, systematic, predictable and logical
solution for oral biofilm management in prophylaxis using state-of-the-art technologies such as
AIRFLOW MAX, PERIOFLOW with AIRFLOW
PLUS powder and PIEZON.
The GBT protocol, which is supported by scientific evidence, was developed in 2016 by EMS,
together with academics, researchers and clinicians across the globe, to overcome all the challenges related to prophylaxis that exist today.
The protocol can be adapted to every clinical situation in the dental practice, from prevention of
early caries and periodontal disease to maintenance and, in many cases, treatment of periodontitis and mucositis. This protocol can be applied
to all patients in supportive periodontal therapy
© EMS
Guided Biofilm Therapy treatment.
and forms the basis of treatment for patients in
initial, non-surgical, periodontal therapy.
GBT involves eight steps that can be modified depending on the clinical situation. The aim
of this protocol is to be minimally invasive, preserve hard and soft tissue, and meet patient ex-
AD
REGISTER FOR FREE
DT Study Club – e-learning community
THE GLOBAL DENTAL CE COMMUNITY
THE GLOBAL DENTAL CE COMMUNITY
THE GLOBAL DENTAL CE COMMUNITY
THE GLOBAL DENTAL CE COMMUNITY
THE GLOBAL DENTAL CE COMMUNITY
Dentistry's largest online
education community
webinars / live operations / online CE events / CE credits
www.dtstudyclub.com
@DTStudyClub
Tribune Group is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist
dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse
individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.This continuing education
activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition
Program (ADA CERP) through joint efforts between Tribune Group and Dental Tribune Int. GmbH.
12
15 and 16 June 2022
pectations. Like any innovation that comes into
being in this day and age, when recommendations on correct usage are followed, this protocol
has been proved to be highly efficacious, safe
and comfortable, not only for the clinician but
also for the patient.
Following the patient thorough periodontal
screening and recording of the results and using a disclosing agent to visualise biofilm not
only guides the patient towards pursuing better
oral hygiene but also aids the clinician in
achieving more efficient, predictable supragingival biofilm removal. Disclosing the biofilm
also enables the clinician to build trust and confidence with the patient, since it assures quality
clinical outcomes. Additionally, it improves patient motivation and helps re-educate patients
on efficacious tooth cleaning, especially in areas
in the mouth that are often neglected or are difficult to access.
Using the AIRFLOW technology with the
Guided Laminar AIRFLOW MAX in probing
depths up to 4 mm and the PERIOFLOW nozzle
in deep pockets up to 9 mm with erythritolbased PLUS powder removes all supragingival
and subgingival biofilm in the most minimally
invasive and highly comfortable way. This helps
to visualise all the supragingival calculus easily,
avoiding over-instrumentation.
The erythritol-based PLUS powder is a
unique, versatile solution that removes all s
upragingival and subgingival biofilm in only
one step. It contains particles of approximately
14 μm, causes the patient no discomfort and
preserves the natural integrity of teeth, dental
implants, restorations, orthodontic appliances
and prostheses.
If any hard calculus remains, use is made of
piezoceramic ultrasonic technology by employing the PIEZON NO PAIN PS instrument. This
high-quality, Swiss-made instrument, designed
like a periodontal probe, is not only efficient supragingivally but also removes all stubborn calculus up to 10 mm subgingivally. A clean oral
cavity without stains, biofilm or calculus supports clinicians in better visualising and checking for any caries, white spot lesions and furcations in a much more predictable way.
Enrolling patients in a regular recall system
is highly dependent on their personal experience during treatment. Today, GBT has over
100,000 testimonials from satisfied patients
across the globe.
To conclude, Petersilka et al.’s assertion on
the need for a superior therapy protocol that offers a number of advantages, including patient
preference and operator convenience in relation
to time management, is fulfilled through GBT,
which has been integrated by GBT-certified
practices globally.
EMS will be hosting a symposium at EuroPerio, at which
Prof. Tord Berglundh from the University of Gothenburg
in Sweden, Prof. Patrick Schmidlin from the University of
Zurich in Switzerland and Prof. Axel Spahr from the University of Sydney will talk about their personal experiences
and present scientific evidence related to the GBT protocol. The symposium will take place on 16 June at 10:00. in
Auditorium 15. EuroPerio attendees can find out more
about GBT at the EMS Booth E.16.
Reference
1
Petersilka G, et al. Retrospective analysis of the long-term
effect of subgingival air polishing in supportive periodontal
therapy. J Clin Periodontol. 2021 Feb;48(2):263–271.
© EMS
About the author
Dr Neha Dixit, global lead of clinical affairs
and professional education at the Swiss Dental
Academy (SDA), has been an integral member
of the SDA and EMS since 2009. A periodontist
by training, she is a passionate and enthusiastic clinician who believes in providing education to clinicians globally that is backed by scientific evidence. Dr Dixit has received specialty
training in non-surgical periodontics and has
been a staunch advocate of adopting a non-invasive clinical approach right from her graduation days, even before she joined EMS.
[13] =>
TDI0322_01-24.pdf
Soft tissue augmentation
NovoMatrix®
Reconstructive Tissue Matrix –
the next generation material
NovoMatrix® Reconstructive Tissue Matrix is an acellular dermal matrix
derived from porcine tissue intended for soft tissue applications. The proprietary
LifeCell™ tissue processing is designed to maintain the biomechanical integrity of the tissue,
which is critical to support tissue regeneration.
Indications
Localized gingival augmentation to increase keratinized tissue (KT) around teeth and implants
Alveolar ridge reconstruction for prosthetic treatment
Guided tissue regeneration procedures in recession defects for root coverage
Product features
Consistent thickness (1 mm)
Pre-hydrated
Controlled source
www.biohorizonscamlog.com
Before use, physicians should review all risk information, which can be found in the Instructions for Use attached to the packaging of each NovoMatix®
Reconstructive Tissue Matrix graft. NovoMatrix® is a registered trademark of BioHorizons. They may not be registered in all markets.
©BioHorizons. All rights reserved. Not all products are available in all countries.
Visit us at
our booth E.20
Bone tissue augmentation
MinerOss® A
The allograft for outstandingly
fast bone remodeling [1]
7KHVFLHQWLȴFHYLGHQFHVKRZVWKDWDOORJUDIWVDUHWKHVHFRQGEHVWRSWLRQWRSDWLHQWȆV
own bone compared to other bone substitutes. [2]
%HQHȴWVRI0LQHU2VV®$KXPDQERQHVXEVWLWXWH>ɋȂ@
Optimal osteoconductivity
Fast graft incorporation
Complete remodeling potential
www.biohorizonscamlog.com
[1] Wen et al. J. Periodont. 2019, 1, 734.
[2] Schmitt et al. Clin Oral Implants Res. 2013, 24, 576.
[3] Kloss et al. Clin Oral Implants Res. 2018, 29, 1163.
[4] Solakoglu et al. Clin Implant Dent Relat Res. 2019, 21, 1002-1016.
[5] Kloss et al. Clin Case Rep. 2020, 8, 5.
References available at: www.biohorizonscamlog.com/references_minerossa
MinerOss® is a trademark of BioHorizons®. BioHorizons® is a registered trademark of BioHorizons.
They may not be registered in all markets. ©BioHorizons. All rights reserved. Not all products are available in all countries.
and sign up for:
Hands-on-workshops
and lectures !
[14] =>
TDI0322_01-24.pdf
news
Straumann to host corporate forum at EuroPerio10
Clinical decisions for immediate treatment protocols
phasis on effective softtissue management. From
single-tooth to full-arch
restorations, participants
will be able to see the
different clinical applications of Straumann implants, particular attention being given to the
management and maintenance of the peri-implant
tissue.
The forum will be chaired by Prof. Frank
Schwarz, head of the department of oral surgery and implantology at Goethe University in
Frankfurt in Germany.
Free lunchboxes will be available while
stocks last.
The clinical management of peri-implant tissue around immediate implants is crucial in
modern implant dentistry, as it can substantially influence the treatment outcomes, especially in the aesthetic zone. Under the title “Clinical decisions for immediate treatment protocols”, Straumann will be hosting a corporate forum at EuroPerio10 that will comprehensively
discuss the advantages of immediate treatment
protocols in various clinical indications, emphasising effective soft-tissue management.
Prof. Ronald Jung, president-elect of the
European Association for Osseointegration, and
Dr Helena Francisco, an assistant professor at
the Faculty of Dental Medicine at the University
of Lisbon in Portugal, will be discussing the advantages of immediate treatment protocols in
various clinical indications, placing special em-
How can remote monitoring lead to better treatment outcomes?
DentalMonitoring solutions now available in all Nordic dental markets
A prevailing myth in healthcare is that the
expertise of practitioners is only accessible onsite. The reality is becoming quite different today. With the onset of technological advances
and a desire for convenience from all parties,
remote monitoring is becoming more and more
widespread across medical fields. It is transforming the oral care industry too.
And the findings are interesting: remote
monitoring is leading to better treatment outcomes for patients in dentistry and orthodontics. Why is this the case? With smart solutions like those offered by DentalMonitoring,
practices can provide high-quality treatment
powered by artificial intelligence (AI) for comprehensive scans, consistent monitoring, automated reports and a new level of communication between dentists and patients.
The difference we are seeing here is a major
breakthrough in oral care: remote monitoring is
ushering in an era of proactive treatment plans
instead of reactive troubleshooting. Dentists
can manage patient treatment with a new level
© DentalMonitoring
of control, rather than simply respond to oral
observations after a time lag.
The high-precision scans offered by remote
monitoring open the door to more productive
treatment. DentalMonitoring’s technology can
locate, calculate and evaluate 130 different intraoral observations, monitoring everything from
aligner tracking to bracket debonding or tooth
eruption. This is made possible by the largest
image database in the industry, comprising
1.5 billion dental images. With a level of detection surpassing the range of the human eye, the
scans allow for a better look inside patients’
mouths—and with it, higher-quality treatment.
These scans go beyond simple photographs:
they provide a quality standard for the industry.
A crucial aspect of remote monitoring’s success is its consistency. Imagine the traditional
model. A dentist instructs a patient to follow an
aligner treatment plan, or perhaps a fixed appliance patient is told by his or her dentist to begin
the elastics phase of treatment. They reconvene
six to eight weeks later at the practice and find
that little progress has been made. Was noncompliance the culprit? Is there another problem at play? With DentalMonitoring, practitioners can eliminate the mystery of what happens
in between in-office appointments. The software
takes dentists out of the dark, giving added
access and control over treatment progression.
Remote monitoring allows for early signs of
non-compliance or any other abnormalities to
be detected and swiftly responded to without
waiting weeks for the next in-person appointment.
Consistent monitoring combines with the AIpowered automated reports to completely streamline the process. Not only do DentalMonitoring
solutions consistently monitor patients with high
precision, but their automated reports facilitate a
fast resolution. Instead of leaving dentists to do
their own self-assessment of patient scans—
which could be a time-consuming and involved
process for staff—with automation, notifications
are sent straight to the patient and the staff once
a deviation in treatment is detected by the AI.
Remote monitoring helps dentists, but it is
also the solution patients are looking for. It can
attract a wider range of patients. The digital
transformation is here, and the practices that
give more virtual options to patients will see
greater demand for their services. The ability to
have an appointment anytime and anywhere is
an attractive proposition for patients and can
even boost motivation to stay on top of treatment.
Behind the best oral care is a strong partnership between practitioners and patients. In
that partnership, communication is streamlined, compliance is encouraged, and both parties are on the same page. In a victory for dentists and patients, technology has evolved to allow for an even more connected experience.
With the advent of remote monitoring, treatment outcomes are only improving.
DentalMonitoring is debunking the myth
that virtual care cannot have a personal touch.
Its suite of remote monitoring solutions is designed to decrease chair time, increase compliance and allow for more precise and personalised care.
According to Dr Francis Scriven, one of
the leading orthodontists in the UK, the company’s solutions have added value to his practice and provided clinical benefits. He said:
“DentalMonitoring allows us to monitor our patients’ treatments on a weekly basis rather than
every few months. This new approach of managing my treatments vastly improves the clinical outcome and the efficiency by detecting issues early while greatly enhancing the patient
experience.”
“DentalMonitoring has made orthodontics
more convenient for our patients while boosting
my practice efficiency,” Dr Scriven added.
To learn more about how remote monitoring
has changed the way that orthodontic practices
work today, Dr Scriven will be hosting a live
webinar titled “From blind to connected orthodontics—how to gain more clinical control of
your orthodontic treatments with DentalMonitoring” on 21 June at 7 p.m. CEST.
For more information, please visit dentalmonitoring.com.
Sign up for webinar free
of charge.
14
15 and 16 June 2022
[15] =>
TDI0322_01-24.pdf
([SHULHQFH OLYH WKH IDVWHVW GHQWDO
' 3ULQWLQJ :RUNIORZ
LQ &RSHQKDJHQ DW WKH (XURSHULR
%HOOD &HQWHU
%RRWK & )
6SULQW5D\ (XURSH *PE+
%UXQQHQZHJ
:HLWHUVWDGW *HUPDQ\
6SULQWUD\FRP
PDUNHWLQJHX#VSULQWUD\FRP
[16] =>
TDI0322_01-24.pdf
news
Clinical research provides new perspective
on management of dental biofilm
Johnson & Johnson hosts symposium on the role of essential oil mouthrinse as part of modern biofilm management at EuroPerio10
Consumer healthcare products specialist
Johnson & Johnson is set to unveil new research
at EuroPerio10. This research compares the efficacy for inhibiting the establishment of dental
biofilm of its essential oil mouthrinse and brushing with that of brushing and flossing alone and
also compares the efficacy of the mouthrinse
with that of hygienist-performed flossing.
In order to underpin the efficacy of the essential oil mouthwash, Johnson & Johnson supported two studies, both of which evaluated the
efficacy of various oral hygiene regimens in the
prevention and reduction of plaque. The findings of the two studies will be presented at a
dedicated 1-hour symposium on Thursday,
16 June, at EuroPerio10.
The first study was led by Dr Jeffery L.
Milleman, director for clinical operations and
principal investigator at US-based clinical research team Salus Research, and investigated
the clinical efficacy of supervised mouth rinsing and flossing on plaque over a period of
12 weeks.
The second study was led by Dr Kimberly R.
Milleman, director, compliance specialist, organoleptic judge and gold standard examiner
for Salus Research. The study investigated the
effects of essential oil mouthwash in oral hygiene regimens. This study also covered a period of 12 weeks.
In addition, Prof. Nicole Arweiler, director
and chair of the department of periodontics and
peri-implant diseases at the University of Marburg’s dental school and hospital in Germany,
will discuss contemporary management of the
oral microbiome and dental biofilm during the
session.
EuroPerio10 attendees are invited to join
the lunch seminar on 16 June between 12:30
and 13:30. The session will be held in seminar
room Break Out 2. A product sample can be requested at Booth C2.12.
Editorial note: For details of the studies and references, please
visit www.listerine.eu.
These are the five key trends in digital dentistry in 2022
Dr Rune Fisker, senior vice president of product strategy at 3Shape, discusses this year’s trends
2022 is an exciting year for digital dentistry.
Dentistry is accelerating at lightning speed and
new technology and innovations are coming up
left and right. Here is my take on what we can
expect from digital innovations in dentistry.
The dental platform race has begun
Platforms are disrupting industries and
changing the way we live. The practice management system will remain the cornerstone of
the digital clinic. However, all major dental technology companies are now offering or launching platforms. Who is best positioned to gain the
highest uptake?
Intra-oral scanners
will keep driving digitalisation
The adaption of intra-oral scanners dramatically accelerated in 2021. This is continuing in
2022. Penetration is already reaching 30 %–35 %
in the US and other mature markets. Future
usage of intra-oral scanners will go far beyond
a digital impression replacing an analogue impression.
3D printing and 3D-printed materials
will continue to advance and expand
in application
3D printers are the other hot item in the
digital category. The true game-changer is
3D-printing materials, which are released
every day and constantly being improved. Material development has advanced so dramatically that high-quality splints can be 3D-printed
and such materials were already widely available in 2021. 2022 will most likely be the year
that fully 3D-printed definitive dentures take
off. This will certainly disrupt the removable
dentures market. Ultimately, all indications
have the potential to be 3D-printed. The ques-
tion is to what extent 3D printing will be employed in the clinic.
Artificial intelligence is here
2021 was the year in which artificial intelligence (AI) finally made its mark on CAD/CAM.
For example, 3Shape Automate, a dental design
service that enables a scan to be uploaded to the
cloud and a crown or night guard to be fully designed from the scan using AI, truly disrupted
the market. The technology is making computers and people smarter and faster across all applications in digital dentistry, and there is definitely going to be much more use of AI in 2022.
used to be the missing indication in CAD/CAM.
However, advanced by increased efficiency and
other benefits that digital design and manufacture of dentures offer to clinics, CAD/CAM of
dentures is now seeing triple-digit growth.
Editorial note: Visit 3Shape at EuroPerio10 from 15 to 18 June
in Denmark at Booth C2 23C.
© 3Shape
Digital aligners and dentures
are rapidly being adopted
Driven by consumer demand for beauty,
cosmetic dentistry and clear aligners will continue to push digitalisation forward. Dentures
© 3Shape
About the author
Dr Rune Fisker, senior vice president of product strategy at 3Shape, was the company’s
very first employee. He has and continues to
play an integral role in the development of innovative 3Shape solutions. Fisker’s vision is
that the 3Shape open ecosystem, driven by the
company’s technology, will continue to enable
dental professionals to deliver aesthetic and
predictable dentistry for better patient care.
Fisker holds a PhD from the Technical University of Denmark and is a globally renowned lecturer on digital dentistry.
16
15 and 16 June 2022
[17] =>
TDI0322_01-24.pdf
ANZEIGE
interview
New study findings on Xeal
and TiUltra surfaces with
All-on-4 treatment concept
An interview with Dr Miguel de Araújo Nobre, MALO CLINIC, Portugal
© Nobel Biocare
The pilot study evaluated the clinical outcomes of All-on-4 treatment with new implant and abutment
surfaces: 64 NobelParallel Conical Connection TiUltra implants and 64 Multi-unit Abutments Xeal.
As director of both the research and development department and the oral
hygiene department at MALO CLINIC in Lisbon in Portugal, Dr Miguel de Araújo
Nobre has more than 20 years’ experience as a clinical researcher and has co-authored over 100 scientific publications in international peer-reviewed journals
and six book chapters. In this interview, he outlines the promising results of a
pilot study that he and Dr Ana Ferro, head of the department of oral surgery,
periodontics and implant treatment at the clinic, are currently conducting on
Nobel Biocare’s Xeal abutment surface and TiUltra implant surface with All-on-4
treatment.
© Nobel Biocare
Dr Miguel de Araújo Nobre.
Dr de Araújo Nobre, what made you
adopt the Xeal and TiUltra surfaces?
We have previous experience using anodised surfaces — we started using Nobel Biocare’s TiUnite implant
surface a long time ago — and have up
to 18 years’ follow-up data that prove
that it is a reliable long-term option.
For these new Xeal and TiUltra surfaces, we scrutinised the research beforehand and were particularly interested in the Mucointegration concept.
From our point of view, it fills a gap in
implant dentistry in relation to the
peri-implant complex.
Can you tell us about the aim of this pilot study?
The aim of the study is to evaluate the clinical outcomes, at three years, of
full-arch rehabilitations conducted with the All-on-4 treatment concept using
NobelParallel Conical Connection implants with the TiUltra surface and Multiunit Abutments with the Xeal surface. It’s an ongoing study with 16 patients.
Could you summarise the key results?
We achieved a 100 % survival rate for both implant and abutment with a
mean marginal bone loss of just 0.46 mm after one year. Though some mechanical complications occurred with provisional prosthesis screw fractures, there
was an absence of biological complications and a good and stable soft tissue
response. In a nutshell, these are good results.
We have learned over the years that, if a stable maintenance protocol is
kept up, the majority of implant failures normally occur in the first or second
year of follow-up. Registering a 100 % survival rate during the first year of follow-up is very promising. From a researcher’s point of view, the one-year survival rate is an important indicator of potential long-term success.
Regarding the marginal bone loss results, what can clinicians learn from this,
particularly regarding long-term outcomes?
Often the marginal bone loss level is a predictor of long-term outcome success. When you place an implant, the implant failure likelihood tends to decrease over time. At the same time, the probability of pockets of marginal bone
loss increases. This is the difference between early and late implant failure. For
this study, we recorded an average of 0.46 mm of marginal
Watch a clinical case
bone loss after one year — 0.57 mm in the maxilla and 0.19 mm
video of the All-on-4
concept from
in the mandible. From our perspective, this was a very pleas- thetreatment
study. Case courtesy of
Dr
Ana
Ferro.
ant surprise.
Editorial note:
More information can be found at www.nobelbiocare.com.
EuroPerio10 attendees can find out more at booth E01.
15 and 16 June 2022
17
[18] =>
TDI0322_01-24.pdf
industry
STRAUMANN TLX PROVIDES HIGH PRIMARY STABILITY FOR IMMEDIATE PLACEMENT PROTOCOLS
What do dental professionals
say about TLX?
Immediacy has become a major part of implant dentistry today. It affords several benefits
for both patient and practitioner. In addition, it
allows for exceptional clinical outcomes in less
time than conventional techniques.
However, to achieve the best possible results, clinicians need the right products and
tools. Straumann has long been at the forefront
of cutting-edge solutions in the field. Each product or service is refined and optimised. The
company aims to help dentists overcome the
challenges they face every day.
“Every single time using TLX, I am left
amazed and surprised with the results. I am experiencing a soft-tissue response that I have
never seen before. Following the same protocols as I always did, instead of good results, we
now have excellent outcomes. The fundamental enhancement is unbelievable tissue response, and in challenging areas the tissue forgiveness is superb. For this reason I just can’t
stop using it. My full-arch and single-tooth experience with TLX is very rewarding, not only
Where tissue level
meets immediacy
Straumann TLX is the latest in a long line
of clinically proven implant solutions. It is designed to mimic natural anatomy and respect
the biological width in all dimensions for ideal
soft-tissue conditioning and aesthetics.
Based on the tried-and-tested principles of
the Straumann BLX implant, TLX is manufactured from Roxolid material and features a
SLActive surface. This winning combination
preserves the natural structures, boosts vascularisation, enhances predictability with immediate protocols and reduces healing time in a
wide range of clinical scenarios.1–4
Straumann TLX has been designed for optimal primary stability in all bone classes, and
this innovative new implant system supports
conventional placement and loading procedures for greater flexibility. It also utilises the
same drill set and TorcFit connection as the
BLX implant, which allows for a simplified and
more convenient workflow.
for me but for our patients. Many times over
the years with immediacy,I wished for a product like TLX.” — Dr Abid Faqir
“The future in implant dentistry is with
neck designs combining a smooth surface in
the transmucosal area with a micro-rough surface inside the bone. As the Derks study
showed, moving the micro-gap away from the
bone and having a smooth surface in the
peri-implant sulcus reduces the risk of peri-implant complications.5 TLX combines this concept with an innovative endosteal design, ensuring optimal primary stability, and will open
a range of new clinical possibilities.” — Prof.
Daniel Buser
Editorial note:
A list of references is available from the publisher.
Institut Straumann,
Switzerland
www.straumann.com
Booth E05
LESS CHX—NEW GENERATION OF MOUTHWASHES IS CHANGING THERAPY
Chlorhexidine digluconate (CHX) is considered the gold standard among oral antiseptics,
but its use comes with a number of side effects.
Consequently, there is growing demand for alternative formulations. One antiseptic mouthwash seems to tick the box: Curaprox Perio
plus regenerate. A study conducted by researchers at the University of Bern in Switzerland has shown that Perio plus regenerate
achieves a strong antibacterial effect with less
CHX, thanks to a unique blend of additives.
More than the sum of its parts
CHX has been the go-to oral antiseptic for
treating oral disease caused by biofilm. However, its use often results in tooth discoloration,
taste disturbance and irritation of the oral mucosa. Its bactericidal effect can also disturb the
symbiosis of oral microflora in higher doses or
with prolonged use. In a new approach, Swiss
oral health brand Curaprox has developed Perio
plus regenerate. The percentage of CHX in this
mouthwash has been limited to 0.09% in order
to minimise side effects, and a number of additional active substances boost its overall substantivity and antibacterial activity.
In an in vitro study, researchers from
the University of Bern compared the effect
of different mouthwash solutions, including
Curaprox Perio plus regenerate, against 13 oral
bacteria found in biofilm associated with caries
and periodontal disease. The researchers found
that Perio plus regenerate’s formulation was
active against all 13. With only 0.09 % CHX,
Perio plus regenerate was able to significantly
reduce biofilm formation. Interestingly, the
mouthwash was able to slow down biofilm formation better than were CHX mouthwashes
with a higher percentage of CHX but without
additives.
A change in chemistry,
a change in mentality
The high efficacy of Perio plus regenerate
against biofilm can only be explained by the
synergy of its ingredients. Citrox, an organic
bioflavonoid mix, reduces the viability of biofilm and has a broad antibacterial effect. Xylitol
inhibits biofilm formation, and hyaluronic acid
promotes wound healing and boasts antiinflammatory properties. Lastly, poly-L-lysine
boosts the substantivity of all active compounds in the mouth.
“In recent years, there has been growing
concern about the impact of high doses of CHX
on the oral microbiome,” Curaprox owner Ueli
Breitschmid explained. For over 60 years, the
Swiss brand has been unique in its mission to
move dentistry away from restoration and to
promote holistic oral health products and concepts. “Supplementing a lower dose of CHX
with additives allows dental professionals to
use a lower dose of CHX right away. Our
goal is a mouthwash with the effect of a classic
0.2 % CHX mouthwash, only with fewer side effects. Less CHX means less damage to the microbiome and a healthy symbiosis of the oral
microflora.”
Brushing remains key
All mouthwashes used in the study had a
relatively low effect on already established periodontal biofilm. According to the researchers,
this confirms the general guidelines that
mouthwash treatment during periodontal therapy should always go hand in hand with scaling and root planing. Chemical therapy is an
adjunct to mechanical biofilm removal. In-
18
15 and 16 June 2022
structing patients on correct brushing with a
manual brush and calibrated interdental
brushes remains key.
The study, titled “Anti-biofilm activity of oral
health-care products containing chlorhexidine
digluconate and Citrox”, was published online
on 12 February 2020 in Oral Medicine.
Curaden, Switzerland
www.curaprox.ch
Booth C2.10
[19] =>
TDI0322_01-24.pdf
MORE
ABOUT GBT
[20] =>
TDI0322_01-24.pdf
industry
SPRINTRAY INTRODUCES PRODUCT INNOVATIONS FOR FAST DENTAL 3D-PRINTING WORKFLOW
SprintRay’s global brand ambassador, Usain Bolt, with the company’s dental 3D-printing products.
SprintRay has recently introduced several
new products to dental professionals, namely
its Pro95 S and Pro55 S dental 3D printers and
the extremely fast post-curing system ProCure 2.
The company has also released SprintRay EUcertified resins that enable fast workflows in
under an hour, as well as RayWare Cloud
3D-printing software, which employs artificial
intelligence.
The company was founded in 2014 in the US
and opened its European office in Weiterstadt in
Germany in April 2021. At its 3D Digital Experience Center, SprintRay Europe enables customers to experience all SprintRay solutions live. In
addition, it offers direct customer support and
quality control services from its German base.
The new intelligent features of the Pro S
range of 3D printers offer an upgrade in work-
flow and make the printers even easier to use.
The printers have smart sensors that support
printing preparation and prevent user error.
Additionally, the heated printing platform,
resin tank and novel software deliver exceptional accuracy, and radio frequency identification technology allows Pro S to track the lifetime of each resin tank.
There is also the all-new printing software,
RayWare Cloud. It works with Smart Print AI,
which automatically handles orientation and
layout and builds supporting structures. This
allows the user to start printing in only a few
clicks. Since RayWare is now integrated into
SprintRay Cloud, the user will not have to run
any software updates again.
To complete the 3D-printing workflow,
SprintRay also offers the two-stage, fully auto-
ACTEON GROUP IS MOVING FORWARD
The ACTEON team is excited about joining EuroPerio10 in Copenhagen. During the event,
we will closely work with the dental industry and share the latest innovations that will help
improve dental professionals’ daily workflows.
EuroPerio10 is a fantastic opportunity for us to reach out to our partners and to listen to their feedback in order
to ensure that we are doing
the very best work possible.
ACTEON is a company of
about 800 people and serves
clients in over 120 countries.
Attendance at the event is a
great honour and also a great
responsibility since we want
to bring the best possible
solutions to our clients in a
connected, efficient, effective
and economical way.
Everything that we do at
ACTEON is concerned with
the patient, and our goal is to
deliver excellent patient care
through our service providers around the world. The
workflows that will be presented during EuroPerio10 focus on periodontology and implantology, but there is also a range of other workflows that have been developed, including prosthetic, prophylactic and endodontic workflows. These workflows combine
the best technologies that ACTEON has to offer in imaging, from radiographic and intraoral imaging and software to ultrasonic surgery and conventional ultrasonics and in
precision instruments for everyday procedures. We also have a pharmaceutical line of
products that help make our patients feel comfortable and ensure the efficacy of dental
procedures.
Together, these unique ACTEON products and services help meet the clients’ needs
most efficiently.
We invite our partners to come and visit us at EuroPerio10 in Booth E13, where we
will also hold a Piezotome workshop. We are looking forward to seeing you there.
ACTEON Group, France
www.acteongroup.com
Booth E13
20
15 and 16 June 2022
The new ProCure 2.
mated washing and drying system called
Pro Wash/Dry and the latest post-curing unit,
ProCure 2. Thanks to advancements in thermodynamics and an all-new high-intensity
UVA light module that scans along the complete curing chamber, ProCure 2 significantly
reduces polymerisation times. Whereas crowns
used to take 40 minutes to cure, they now take
less than 2 minutes! For improved efficiency,
users can choose from preset curing profiles
for all SprintRay resins and certified partner
resins.
Besides the hardware and software upgrades, SprintRay has introduced new EUcertified materials. For each indication, users
can choose between SprintRay resins and
resins from the company’s market-leading partners.
Experiencing the next 100 years of dentistry today—this is SprintRay. With a focus on
dental 3D printing, SprintRay is continuously
developing its technology and products to deliver its unique frictionless workflows to dentists and laboratories. The company’s philosophy is shared with SprintRay’s global brand
ambassador, Usain Bolt, an Olympic champion
and world record holder in the 100 m sprint. In
the spirit of this partnership, SprintRay continuously works with “Bolt speed” to make its
solutions even faster, more intuitive and userfriendly.
SprintRay
www.sprintray.com
Booth C3 13F
THE SYMPOSIUM IS BACK
Osstem-Hiossen Meeting in Europe
to take place in autumn
AIC Europe, which was founded in 2001 by
Osstem Implant, has confirmed that the OsstemHiossen Meeting in Europe 2022 will be held as
planned in October in Rome. In addition to a series
of lectures to be presented on various topics related to dental implant procedures, the two-day
symposium will feature a live surgery, a roundtable discussion and an oral competition.
The last European symposium in Prague in the
Czech Republic gathered dentists from more than
30 countries in Europe, the Middle East, Africa and
the US. Owing to the SARS-CoV-2 pandemic, the
symposium has had
to be suspended for
the past two years.
This year, the organisers are looking forward to finally welcoming participants
to a new edition of the
symposium, which
will be held on 28 and
29 October at the Auditorium del Massimo
congress centre in
the city of Rome.
More than 20 renowned experts, including Prof. Bilal alNawas from Germany, Dr Darko Božić from Croatia, Dr Silvio Meloni and Dr Francesco Mintrone
from Italy as well as Waldo Zarco Nosti from Spain,
will be speaking about the latest in implant dentistry. Special guest Dr David Chong from the US
will be opening the symposium.
The last session on the first day will be dedicated to a round-table discussion, in which
Dr Marco Tallarico from Italy, Dr Hyun-Jun Jung
from Korea and Dr Chong will explain different
approaches to the maxillary reconstruction of terminal dentition.
A highlight of the symposium will be the live
surgery that will be performed on the second day
by Dr Jung and Dr Roberto Scrascia from Italy.
Moreover, dentists and dental students will have
the opportunity to present their cases in an oral
competition or in the poster zone. Abstracts can
now be submitted in three categories digital dentistry, prosthetics and oral surgery. After review
by the symposium committee, applicants will be
informed whether they will be joining the oral
presentation or exhibiting in the poster zone.
On Friday night, a gala dinner featuring the
finest Italian cuisine will offer great networking
opportunities in a relaxed atmosphere. Cultural
performances will entertain the guests.
The whole symposium will be livestreamed
through Osstem’s own global broadcasting system,
DenAll TV, and other related channels.
For more information, please visit www.osstemeurope-meeting.com.
[21] =>
TDI0322_01-24.pdf
PROTECT
YOUR
PATIENTS
THE ‘PERIO PLUS
REGENERATE’ REVOLUTION:
+ Inspiring fresh taste sensation
+ Proven more effective
than pure CHX*
+ Regeneration and protection of
oral mucosa
+ Additional protection against
infections* and the causes of bad
breath
*Studies on www.perioplus.com/studies
HE
T
T
A
S
U
VISIT
STAND
10
.
2
C
.
O
N
FIN
AT
W
O
N
E
OR
M
T
U
O
D
M
O
C
.
X
O
R
CURAP
[22] =>
TDI0322_01-24.pdf
travel
What’s on in Copenhagen, 15–18 June
3daysofdesign
• Dates: From 15 to 17 June
• More information: 3daysofdesign.dk
most iconic waterfront and is perfect for a leisurely day stroll or a sightseeing boat tour. The district
is also known for its entertainment and offers numerous cafes, bars, restaurants and live music venues for those wishing to experience Copenhagen’s lively nightlife.
© Filippo Bamberghi/3daysofdesign
© Nick N A/Shutterstock.com
3daysofdesign is a major design fair in Copenhagen and is considered to be the most important
event of its kind in the country. Offering over 200 exhibitors this year, the festival is inviting design
enthusiasts interested in lifestyle, furniture, lighting and interior design concepts to visit the showrooms, galleries, exhibitions and shops of some prominent design brands from the Danish capital.
The annual three-day festival attracts people from all walks of life and offers a unique opportunity
to explore the vibrant design scene that Denmark is known for.
Smørrebrød
• Suggested restaurant: Schønnemann,
Hauser Pl. 16, 1127 København K
© Hamish Gray/Shutterstock.com
Tivoli
• Opening hours: 11:00 to 22:00 Sunday–Thursday;
11:00 to 00:00 Friday–Sunday
• Entry: From DKK 145 (€19)
• Location: Vesterbrogade 3, 1630 København V
• More information: www.tivoli.dk
© ESB Professional/Shutterstock.com
“Smørrebrød” is Danish for “butter” (“smør”) and “bread” (“brød”). As the name suggests, smørrebrød is a traditional Danish open-faced sandwich that consists of a slice of buttered rye bread layered with any of a variety of gourmet toppings, such as pickled herring, roast beef, eggs and shrimps.
Garnished with herbs or slices of raw red onion and radish, among others, smørrebrød is definitely
a feast for the eyes and one of Denmark’s most famous dishes.
about the publisher
Publisher and Chief Executive Officer
Torsten R. Oemus
Tivoli Gardens is an amusement park and pleasure garden in Copenhagen. The park opened
almost two centuries ago, in 1843, and is the third-oldest operating amusement park in the world.
With around 30 rides suitable for both adults and children, Tivoli is one of the most visited tourist sites in Denmark. Besides the thrilling and daring attractions, visitors to Tivoli are invited to
enjoy exotic architecture and lush vegetation, choose from a selection of restaurants, including
those offering traditional Danish cuisine, and immerse themselves in a wide range of live music
concerts.
Nyhavn waterfront
• Location: Nyhavn, København K
The essence of Copenhagen’s picturesque scenery is its captivating waterfronts. Beaches, lakes,
harbours, water parks and swimming pools—the city has it all, including a seventeenth-century canal. Known for its bright colours, historical ships and rowdy sailor stories, Nyhavn is Copenhagen’s
22
15 and 16 June 2022
Chief Content Officer
Claudia Duschek
Editors
Franziska Beier
Jeremy Booth
Brendan Day
Anisha Hall Hoppe
Iveta Ramonaite
Copy Editors
Ann-Katrin Paulick
Sabrina Raaff
Designer
Matthias Abicht
Production Executive
Gernot Meyer
Advertising Disposition
Marius Mezger
Dental Tribune International GmbH
Holbeinstraße 29
04229 Leipzig
Germany
Tel.: +49 341 48474-302
Fax: +49 341 48474-173
General requests: info@dental-tribune.com
Sales requests: mediasales@dental-tribune.com
www.dental-tribune.com
The newspaper and materials therein are copyrighted by Dental Tribune International GmbH. Dental Tribune International GmbH makes every effort to report
clinical information and manufacturers’ product news accurately but cannot
assume responsibility for the validity of product claims or for typographical
errors. The publisher also does not assume responsibility for product names,
claims or statements made by advertisers. Opinions expressed by authors
are their own and may not reflect those of Dental Tribune International GmbH.
General terms and conditions apply; legal venue is Leipzig, Germany.
All rights reserved.
© 2022 Dental Tribune International GmbH. Reproduction in any manner in any
language, in whole or in part, without the prior written permission of Dental
Tribune International GmbH is expressly prohibited.
[23] =>
TDI0322_01-24.pdf
Leading virtual
orthodontic
solutions
Augment practice productivity
and deliver outstanding patient experience.
Engage more qualified patients: via AI-powered initial assessments and virtual consultations.
Drive higher case acceptance: with instant ultra-realistic smile simulations.
Control treatments remotely: thanks to an automated workflow and clinical goals that you set
AD_VIP_AD_038_01_rd_A_EU_en
(suited for all fixed and removable appliances of all brands).
dental-monitoring.com
Already trusted by 7,000+ practices and 1M+ patients worlwide
DentalMonitoring, Smilemate and Vision are products designed and manufactured by Dental Monitoring SAS, under the DentalMind branding for Health Care Professional (HCP). They are
also used by patients under the mandatory supervision of Health Care Professional (HCP). DentalMonitoring and SmileMate are designed to assist HCP in observing remotely intra-oral situations (and monitor orthodontic treatments for DentalMonitoring). Refer to your HCP and/or the Instructions for Use before use. DentalMonitoring product is a medical device (in Europe
only), registered as such and holding the CE mark. Vision simulations are generated using artificial intelligence, they are not contractual and may differ from the final results of the patient’s
treatment. Products availability, claims and regulatory status may differ across countries depending on local regulations. Contact your local representative for further information.
[24] =>
TDI0322_01-24.pdf
)
[page_count] => 24
[pdf_ping_data] => Array
(
[page_count] => 24
[format] => PDF
[width] => 794
[height] => 1134
[colorspace] => COLORSPACE_UNDEFINED
)
[linked_companies] => Array
(
[ids] => Array
(
)
)
[cover_url] =>
[cover_three] =>
[cover] =>
[toc] => Array
(
[0] => Array
(
[title] => EFP welcomes attendees to EuroPerio10 in Copenhagen
[page] => 1
)
[1] => Array
(
[title] => Interview: “I am looking forward to the best EuroPerio ever”
[page] => 4
)
[2] => Array
(
[title] => News
[page] => 6
)
[3] => Array
(
[title] => Interview: New study findings on Xeal and TiUltra surfaces with All-on-4 treatment concept
[page] => 17
)
[4] => Array
(
[title] => Industry
[page] => 18
)
[5] => Array
(
[title] => What’s on in Copenhagen, 15–18 June
[page] => 22
)
)
[toc_html] =>
[toc_titles] => EFP welcomes attendees to EuroPerio10 in Copenhagen
/ Interview: “I am looking forward to the best EuroPerio ever”
/ News
/ Interview: New study findings on Xeal and TiUltra surfaces with All-on-4 treatment concept
/ Industry
/ What’s on in Copenhagen, 15–18 June
[cached] => true
)